BR0012301A - Inibidores de crescimento de células epiteliais - Google Patents

Inibidores de crescimento de células epiteliais

Info

Publication number
BR0012301A
BR0012301A BR0012301-3A BR0012301A BR0012301A BR 0012301 A BR0012301 A BR 0012301A BR 0012301 A BR0012301 A BR 0012301A BR 0012301 A BR0012301 A BR 0012301A
Authority
BR
Brazil
Prior art keywords
epithelial cell
cell growth
growth inhibitors
epithelial
ecgi
Prior art date
Application number
BR0012301-3A
Other languages
English (en)
Inventor
Raul R Ervin Jr
Original Assignee
Biotherapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotherapies Inc filed Critical Biotherapies Inc
Publication of BR0012301A publication Critical patent/BR0012301A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: "INIBIDORES DE CRESCIMENTO DE CéLULAS EPITELIAIS". Os inibidores de crescimento de células epiteliais diferencialmente expressam em células epiteliais cancerosas e normais. As proteínas ECGI e sequência de ácido nucleico codificando as mesmas são utilizáveis no diagnóstico e tratamento de cânceres de células epiteliais, por exemplo próstata, ovariano, câncer do cólon e outros.
BR0012301-3A 1999-06-18 2000-06-19 Inibidores de crescimento de células epiteliais BR0012301A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13999599P 1999-06-18 1999-06-18
PCT/US2000/016900 WO2000078955A1 (en) 1999-06-18 2000-06-19 Epithelial cell growth inhibitors

Publications (1)

Publication Number Publication Date
BR0012301A true BR0012301A (pt) 2002-03-26

Family

ID=22489251

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012301-3A BR0012301A (pt) 1999-06-18 2000-06-19 Inibidores de crescimento de células epiteliais

Country Status (13)

Country Link
EP (1) EP1190054A1 (pt)
JP (1) JP2003513615A (pt)
KR (1) KR20020016837A (pt)
CN (1) CN1399680A (pt)
AU (1) AU783373B2 (pt)
BR (1) BR0012301A (pt)
CA (1) CA2375498A1 (pt)
IL (1) IL147148A0 (pt)
MX (1) MXPA01013242A (pt)
NZ (1) NZ516545A (pt)
PL (1) PL352997A1 (pt)
WO (1) WO2000078955A1 (pt)
ZA (1) ZA200200145B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500937B1 (en) 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
WO2001098496A1 (en) * 2000-06-19 2001-12-27 The University Of Michigan Mammastatin sequence variant c
CN102787092B (zh) * 2011-05-17 2018-01-09 李晖 培养基、细胞培养用试剂盒及细胞培养方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031625A1 (en) * 1995-04-07 1996-10-10 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
EP0929675A2 (en) * 1996-10-03 1999-07-21 Biotherapies, Inc. Nucleotide and protein sequence of mammastatin and methods of use
US6500937B1 (en) * 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor

Also Published As

Publication number Publication date
WO2000078955A1 (en) 2000-12-28
MXPA01013242A (es) 2002-11-04
CA2375498A1 (en) 2000-12-28
JP2003513615A (ja) 2003-04-15
AU783373B2 (en) 2005-10-20
IL147148A0 (en) 2002-08-14
CN1399680A (zh) 2003-02-26
NZ516545A (en) 2004-06-25
KR20020016837A (ko) 2002-03-06
WO2000078955A9 (en) 2002-09-06
AU6052300A (en) 2001-01-09
ZA200200145B (en) 2003-04-30
PL352997A1 (en) 2003-09-22
EP1190054A1 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
TR199701462T1 (xx) DNA Dizisi ve bununla kodlanm�� meme'ye �zel g���s kanseri proteini.
BR0109062A (pt) Inibidores de frutose-1,6-bisfosfatase de arila
BR0315666A (pt) Dna de a34 e a33 do tipo 3, proteìnas, seus anticorpos e métodos de tratamento usando os mesmos
WO2003004989A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
DK1112275T3 (da) Hidtil ukendte heteroaromatiske inhibitorer for fructose-1,6-bisphosphatase
DE60214134D1 (de) Modifizierte psma-liganden und deren verwendung
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
DE69837529D1 (de) Proteinmarker für lungenkrebs und deren verwendung
WO2003050243A3 (en) Novel genes encoding colon cancer antigens
WO2002071928A3 (en) Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
ATE402188T1 (de) Bindungsproteine als biosensoren
WO2003000012A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
WO2002078598A3 (en) Peptides and antibodies to muc 1 proteins
DK1007537T3 (da) Receptor-protein med betegnelsen 2F1
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
WO2000055629A3 (en) Methods of diagnosing and treating breast cancer
AU2740100A (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
WO2002031209A3 (en) Genes related to development of refractory prostate cancer
DK1082423T3 (da) Cyclin E2-gener og -proteiner
DE60044350D1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
BR0012301A (pt) Inibidores de crescimento de células epiteliais
NZ516237A (en) Meth1 and meth2 polynucleotides and polypeptides
SE9500030D0 (sv) Method of determining metastatic potential of tumor cells
WO2002081640A3 (en) Gene shinc-1 and diagnostic and therapeutic uses thereof
DE69733491D1 (de) In Krebszellen überexprimiertes Genprodukt

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A, 6A, E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.